Ali Ikhwan

Transparency and Oversight: A Comprehensive Analysis of PEPFAR’s Congressional Reporting Mandates

• Breast Cancer Legislation and Policy

Transparency and Oversight: A Comprehensive Analysis of PEPFAR’s Congressional Reporting Mandates

Ali Ikhwan May 15, 2026 0

Since its inception in 2003, the President’s Emergency Plan for AIDS Relief (PEPFAR) has stood as the...

Read More Read more about Transparency and Oversight: A Comprehensive Analysis of PEPFAR’s Congressional Reporting Mandates

New Federal Mandates Reshape Medicaid: A Deep Dive into the 2027 Work Requirement Landscape

• Breast Cancer Legislation and Policy

New Federal Mandates Reshape Medicaid: A Deep Dive into the 2027 Work Requirement Landscape

Ali Ikhwan May 14, 2026 0

The landscape of American public health policy is undergoing a profound transformation. Under the provisions of the...

Read More Read more about New Federal Mandates Reshape Medicaid: A Deep Dive into the 2027 Work Requirement Landscape

The Grounded Revolution: Navigating the New Moon in Taurus

• Integrative Oncology and Holistic Care

The Grounded Revolution: Navigating the New Moon in Taurus

Ali Ikhwan May 14, 2026 0

Published May 14, 2026 As the celestial calendar turns toward mid-May, the cosmos prepares for a significant...

Read More Read more about The Grounded Revolution: Navigating the New Moon in Taurus

From Patient to Practitioner: How One Mother’s Cancer Journey Inspired a Life of Service

• Survivorship and Post-Treatment

From Patient to Practitioner: How One Mother’s Cancer Journey Inspired a Life of Service

Ali Ikhwan May 14, 2026 0

By Medical Editorial Staff | March 27, 2026 Every year on May 6, the global medical community...

Read More Read more about From Patient to Practitioner: How One Mother’s Cancer Journey Inspired a Life of Service

UK’s Ambitious 150-Day Clinical Trial Set-Up Target: A Deep Dive into the NIHR’s Strategic Role

• Medical Research and Clinical Trials

UK’s Ambitious 150-Day Clinical Trial Set-Up Target: A Deep Dive into the NIHR’s Strategic Role

Ali Ikhwan May 14, 2026 0

London, UK – [Date of Publication] – The United Kingdom is making a concerted effort to solidify...

Read More Read more about UK’s Ambitious 150-Day Clinical Trial Set-Up Target: A Deep Dive into the NIHR’s Strategic Role

Create Medicines Secures $122M Series B to Pioneer “In Vivo” CAR-T Revolution

• Treatment Innovations

Create Medicines Secures $122M Series B to Pioneer “In Vivo” CAR-T Revolution

Ali Ikhwan May 14, 2026 0

By Delilah Alvarado | May 14, 2026 In a significant vote of confidence for the next generation...

Read More Read more about Create Medicines Secures $122M Series B to Pioneer “In Vivo” CAR-T Revolution

Bridging the Diagnostic Gap: Could a New Blood Test Revolutionize Peripheral Arterial Disease Detection?

• Clinical Radiology and Imaging

Bridging the Diagnostic Gap: Could a New Blood Test Revolutionize Peripheral Arterial Disease Detection?

Ali Ikhwan May 11, 2026 0

By Science Correspondent Peripheral Arterial Disease (PAD) has long been described as a "silent" epidemic. Affecting an...

Read More Read more about Bridging the Diagnostic Gap: Could a New Blood Test Revolutionize Peripheral Arterial Disease Detection?

GSK Fortifies Hepatitis B Strategy with Strategic Sino Biopharmaceutical Partnership

• Treatment Innovations

GSK Fortifies Hepatitis B Strategy with Strategic Sino Biopharmaceutical Partnership

Ali Ikhwan May 11, 2026 0

By Delilah Alvarado | May 11, 2026 In a move signaling a deepening commitment to the Chinese...

Read More Read more about GSK Fortifies Hepatitis B Strategy with Strategic Sino Biopharmaceutical Partnership

The Rise, Fall, and Lessons of Melflufen: A Turning Point in Multiple Myeloma Therapy

• Clinical Oncology Education

The Rise, Fall, and Lessons of Melflufen: A Turning Point in Multiple Myeloma Therapy

Ali Ikhwan May 11, 2026 0

The history of melflufen (melphalan flufenamide) in the treatment of relapsed or refractory multiple myeloma (RRMM) serves...

Read More Read more about The Rise, Fall, and Lessons of Melflufen: A Turning Point in Multiple Myeloma Therapy

Revolutionizing Oncology: ArteraAI Secures FDA Clearance for Landmark Breast Cancer Risk Assessment Tool

• Treatment Innovations

Revolutionizing Oncology: ArteraAI Secures FDA Clearance for Landmark Breast Cancer Risk Assessment Tool

Ali Ikhwan May 10, 2026 0

In a significant leap forward for precision oncology, Artera has announced that its innovative ArteraAI Breast software...

Read More Read more about Revolutionizing Oncology: ArteraAI Secures FDA Clearance for Landmark Breast Cancer Risk Assessment Tool